[1] Htay H, Johnson DW, Wiggins KJ, et al. Biocompatible dialysis fluids for peritoneal dialysis[J]. Cochrane Database Syst Rev, 2018, 10: CD007554. doi: 10.1002/14651858.CD007554.pub3. [2] Wang J, Wang L, Xu L, et al. Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition[J]. Oncotarget, 2017, 8: 83872- 83889. [3] Takeuchi O, Akira S. Pattern recognition receptors and inflammation[J]. Cell, 2010, 140: 805-820. [4] 高源, 郑刚, 齐靖, 等. NLRP3炎性小体在心脏病发病中的作用研究进展[J]. 基础医学与临床, 2023, 43: 1162-1166. [5] Hishida E, Ito H, Komada T, et al. Crucial role of NLRP3 inflammasome in the development of peritoneal dialysis-related peritoneal fibrosis[J]. Sci Rep, 2019, 9: 10363. doi: 10.1038/s41598-019-46504-1 [6] El Agha E, Kramann R, Schneider RK, et al. Mesenchymal stem cells in fibrotic disease[J]. Cell Stem Cell, 2017, 21: 166-177. [7] Xiang E, Han B, Zhang Q, et al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis[J]. Stem Cell Res Ther, 2020,11: 336. doi: 10.1186/s13287-020-01852-y. [8] 陈莉莉, 孙永红, 雷晓燕, 等. 间充质干细胞外泌体治疗肺部疾病的研究进展[J]. 基础医学与临床, 2023, 43: 192-195. [9] Janockova J, Slovinska L, Harvanova D, et al. New therapeutic approaches of mesenchymal stem cells-derived exosomes[J]. J Biomed Sci, 2021, 28: 39. doi: 10.1186/s12929-021-00736-4. [10] Rong X, Liu J, Yao X, et al. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway[J]. Stem Cell Res Ther, 2019, 10: 98. doi: 10.1186/s13287-019-1204-2. [11] Zhao JL, Guo MZ, Zhu JJ, et al. Curcumin suppresses epithelial-to-mesen chymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1)[J]. Cell Mol Biol Lett, 2019, 24: 32. doi: 10.1186/s11658-019-0157-x. [12] Balzer MS. Molecular pathways in peritoneal fibrosis[J]. Cell Signal, 2020, 75: 109778. doi: 10.1016/j.cellsig.2020.109778. [13] Bochon B, Kozubska M, Surygała G, et al. Mesenchymal stem cells potential applications in kidney diseases[J]. Int J Mol Sci, 2019, 20: 2462. doi: 10.3390/ijms20102462. [14] Shao L, Zhang Y, Lan B, et al. miRNA-sequence indica-tes that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair[J]. Biomed Res Int, 2017, 2017: 4150705. doi: 10.1155/2017/4150705. |